Xeraya Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Xeraya Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 1, 2021	OncoMyx Therapeutics	$50.0M Series B	B Capital Group, Benjamin Rovinski, Ph.D.	Boehringer Ingelheim, City Hill Ventures, Delos Capital, Korea Investment Partners, LYZZ Capital, Madison Partners
Mar 16, 2021	Rapid Micro Biosystems	$81.0M Other Equity	D1 Capital Partners	Adage Capital Management, Ally Bridge Group, Asahi Kasei Medical, Bain Capital Life Sciences, BlackRock, CaaS Capital Management, Endeavour Vision, Longitude Capital, Quaker Partners, Sunley House Capital, T. Rowe Price Associates
Nov 19, 2020	Imago BioSciences, Inc.	$80.0M Series C	Farallon Capital Management	Amgen Ventures, BlackRock, Blackstone, Frazier Healthcare Partners, Greenspring Associates, Irving Investors, Kingdon Capital, MRL Ventures Fund, Omega Funds, Pharmaron, Surveyor Capital, T. Rowe Price Associates
Nov 1, 2020	InterVenn	$34.0M Series B	Anzu Partners	Amplify Partners, Genoa Ventures, Mango Capital, NFX, Northpond Ventures, Outlier Ventures, Redpoint Ventures, True Ventures, Uncork Capital, Adam Gross, Amit Agarwal, Gerhard Eschelbeck, Spencer Kimball, Stani Kulechov, Ojjeh Family
Oct 1, 2020	Congenica	$50.0M Series C	Jess McCreadie, Ling Ge	Future Planet Capital, Jonathan Milner, Parkwalk Advisors, Cambridge Innovation Capital, Downing Ventures, IDO Investments
May 20, 2020	Rapid Micro Biosystems	$120.0M Other Equity	Frank Yu	Asahi Kasei Medical, Bain Capital Life Sciences, Alexander Schmitz, David Hirsch
May 12, 2020	Greenlight Biosciences	$17.0M Other Equity	—	Michael Liang, Flu Lab
Feb 1, 2020	Aria CV	$31.0M Series B	Jason Rushton	BioStar Ventures, Broadview Ventures, Darshana Zaveri, Cedar Point Capital, Frontcourt Group, Maria Berkman
Jan 1, 2020	P2 Science	$12.0M Series C	Chanel, Kip Frey	Connecticut Innovations, BASF Venture Capital, Elm Street Ventures, Ironwood Capital, Safer Made
Jun 20, 2019	Acutus Medical	$170.0M Debt / Series D	—	Vince Burgess, Advent Venture Partners, Deerfield Management, GE Ventures, Opaleye Management, OrbiMed, Pura Vida Investments
Jun 5, 2019	OncoMyx Therapeutics	$25.0M Series A	Kanad Das, Tim Xiao, Jason Rushton	City Hill Ventures, Korea Investment Partners, Madison Partners
May 2, 2018	Rapid Micro Biosystems	$60.0M Other Equity	Jeff Schwartz, Fares Zahir	Asahi Kasei Medical, Longitude Capital, Quaker Partners, TVM Capital
Sep 1, 2016	Chrono Therapeutics	$48.0M Series B	Kaiser Permanente Ventures	5AM Ventures, Canaan Partners, SR One Capital Management, Asahi Kasei, Wende Hutton, Cota Capital, Emergent Medical Partners, Endeavour Vision, Fountain Healthcare Partners, GE Ventures, Hikma Ventures, Mayo Clinic, Mission Bay Capital
Aug 1, 2016	Iconic Therapeutics	$10.0M Series C	Fares Zahir	MPM Capital, Cormorant Asset Management, Matthias Fehr, H.I.G. BioHealth Partners, Lundbeckfond Ventures, Osage University Partners
Mar 1, 2016	Acutus Medical	$75.0M Series C	—	Aberdare Ventures, Advent Life Sciences, GE Ventures, MPM Capital, Advent Life Sciences, Steve Hochberg, OrbiMed
Oct 19, 2015	Boston Neurosciences Inc	$10.0M Series A	Xeraya Capital	—